Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;45(10):2700-2709.
doi: 10.1002/hed.27466. Epub 2023 Aug 8.

Early screening of nasopharyngeal carcinoma

Yue Yuan  1   2 , Fei Ye  1   2   3 , Jian-Hui Wu  2 , Xiao-Yan Fu  4   5 , Zhong-Xi Huang  6 , Tao Zhang  1
Affiliations
Review

Early screening of nasopharyngeal carcinoma

Yue Yuan et al. Head Neck. 2023 Oct.

Abstract

The low positive predictive value (PPV) of early screening of nasopharyngeal carcinoma (NPC) is the problems that need to be solved urgently. The combination of cell-free DNA (cfDNA) methylation testing and Epstein-Barr virus (EBV) serological testing is the key to solve this problem. This paper reviews recent advances in early screening for NPC and cfDNA methylation, with future perspectives. Pubmed was searched for the literature related to early screening of NPC and cfDNA methylation in the past 5 years. The results of these studies were summarized. Despite these efforts, the PPV is still low (10%). Previous studies have shown that cfDNA methylation analysis has good specificity and accuracy across a variety of tumors. The combination of cfDNA methylation and EBV detection helps to improve the PPV for early screening of NPC. The combination of cfDNA methylation and EBV serological testing is key to addressing the low PPV of NPC early screening.

Keywords: DNA methylation; EBV; cfDNA; early screening; nasopharyngeal carcinoma.

PubMed Disclaimer

References

REFERENCES

    1. EAR ENS, Irekeola AA, Yean CY. Diagnostic and prognostic indications of nasopharyngeal carcinoma. Diagnostics (Basel). 2020;10(9):611.
    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
    1. Chen YP, Chan ATC, le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64-80.
    1. Du Y, Zhang W, Lei F, et al. Long-term survival after nasopharyngeal carcinoma treatment in a local prefecture-level hospital in southern China. Cancer Manag Res. 2020;12:1329-1338.
    1. Ji MF, Sheng W, Cheng WM, et al. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Ann Oncol. 2019;30(10):1630-1637.

MeSH terms

LinkOut - more resources